Revenue for Revvity (RVTY)
According to Revvity's latest reported financial statements, the company's current revenue (TTM) is $2.86B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

RVTY
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$2.86B
YoY change
+3.7%
5Y CAGR
-5.5%
Peak year (2021)
$3.83B
Cumulative revenue
$83.03B
Revenue history chart for Revvity (RVTY) from 1985 to 2025
Revenue history table for Revvity (RVTY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $2.86B | +3.7% | ||
| 2024 | $2.76B | +0.2% | ||
| 2023 | $2.75B | -16.9% | ||
| 2022 | $3.31B | -13.5% | ||
| 2021 | $3.83B | +1.2% | ||
| 2020 | $3.78B | +31.2% | ||
| 2019 | $2.88B | +3.8% | ||
| 2018 | $2.78B | +23.1% | ||
| 2017 | $2.26B | +6.7% | ||
| 2016 | $2.12B | +0.5% | ||
| 2015 | $2.10B | -5.9% | ||
| 2014 | $2.24B | +3.3% | ||
| 2013 | $2.17B | +2.4% | ||
| 2012 | $2.12B | +10.1% | ||
| 2011 | $1.92B | +12.7% | ||
| 2010 | $1.70B | +9.9% | ||
| 2009 | $1.55B | -20.9% | ||
| 2008 | $1.96B | +9.7% | ||
| 2007 | $1.79B | +15.6% | ||
| 2006 | $1.55B | +4.9% | ||
| 2005 | $1.47B | +3.1% | ||
| 2004 | $1.43B | -6.9% | ||
| 2003 | $1.54B | +2.0% | ||
| 2002 | $1.50B | +13.2% | ||
| 2001 | $1.33B | -21.5% | ||
| 2000 | $1.70B | +24.4% | ||
| 1999 | $1.36B | -3.2% | ||
| 1998 | $1.41B | -3.6% | ||
| 1997 | $1.46B | +2.3% | ||
| 1996 | $1.43B | +0.5% | ||
| 1995 | $1.42B | +6.5% | ||
| 1994 | $1.33B | -50.6% | ||
| 1993 | $2.70B | -3.3% | ||
| 1992 | $2.79B | +3.7% | ||
| 1991 | $2.69B | +8.7% | ||
| 1990 | $2.47B | +49.9% | ||
| 1989 | $1.65B | +17.3% | ||
| 1988 | $1.41B | +13.8% | ||
| 1987 | $1.24B | +7.9% | ||
| 1986 | $1.15B | -0.9% | ||
| 1985 | $1.16B | — |
Revenue values are taken from Revvity's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Revvity (RVTY) reported revenue of $2.86B – edged up 3.7% year-over-year.
Across 2020–2025 (5 years), Revvity revenue produced a CAGR of -5.5% – sustaining 2 straight years of year-over-year growth.
Revvity revenue peaked at $3.83B in 2021; the latest annual figure is $2.86B in 2025 (25.4% below peak).
The dataset's maximum revenue sits at $3.83B (2021); the minimum reading of $1.15B dates to 1986.
Revvity (RVTY) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
Revvity Revenue by Year
Revvity Revenue 2025: $2.86B
Revvity revenue in 2025 was $2.86B, edged up 3.7% from 2024.
Revvity Revenue 2024: $2.76B
Revvity revenue in 2024 was $2.76B, edged up 0.2% from 2023.
Revvity Revenue 2023: $2.75B
Revvity revenue in 2023 was $2.75B, declined 16.9% below 2022.
Revvity Revenue 2022: $3.31B
Revvity revenue in 2022 was $3.31B, declined 13.5% below 2021.
Revvity Revenue 2021: $3.83B
Revvity revenue in 2021 was $3.83B.
See more financial history for Revvity (RVTY).
Sector peers — Revenue
Companies in the same sector as Revvity, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Revvity's revenue?
- Latest reported revenue for Revvity (RVTY) is $2.86B (period ending December 28, 2025).
How has Revvity revenue changed year-over-year?
- Revvity (RVTY) revenue changed +3.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Revvity revenue?
- Revvity (RVTY) revenue compound annual growth rate is -5.5% over the most recent 5 years available.
When did Revvity revenue hit its highest annual value?
- Revvity revenue reached its highest annual value of $3.83B in 2021.
What was Revvity revenue in 2024?
- Revvity (RVTY) revenue in 2024 was $2.76B.
What was Revvity revenue in 2025?
- Revvity (RVTY) revenue in 2025 was $2.86B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
RVTY Overview
Company profile, financial tools, and key metrics
RVTY Revenue Counter
Earns $90.56 every second. See per minute, hour, and day.
RVTY Earnings Counter
Earns $7.66 per second net profit. See per minute, hour, and day.
RVTY Economic Scale
Exceeds Central African Republic's GDP. Compare with world economies.
RVTY What If Invested
What if you had invested $1,000? See historical returns from any date.
RVTY How It Makes Money
Discover visual breakdown of $2.86B in revenue — where it comes from and where it goes.
RVTY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
RVTY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
RVTY Daily Price Character
Balanced · 46.1% historical win rate (green days). Streaks & record days.
RVTY Buybacks
7.47% TTM buyback yield. Shareholder yield & SBC comparison.
RVTY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
RVTY Dividend Profile
Yield: 0.34%. Safety: 4/8. See full history.
RVTY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
RVTY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.